Neuroinflammation is a vital immune response within the central nervous system (CNS), predominantly orchestrated by microglia and astrocytes. It is not merely a byproduct of neurodegeneration but also a pivotal catalyst in this process. These cells are the primary sources of inflammatory factors in neuroinflammation and are implicated in nearly all neurodegenerative diseases, including Alzheimer's and Parkinson's.
Several signaling pathways have been identified as being integral to the genesis of neuroinflammation. To advance our understanding and facilitate drug evaluation in this field, ICE has established a comprehensive neuroinflammation drug evaluation platform. This platform is designed to study the complex interplay of these pathways and to test potential therapeutics aimed at mitigating neuroinflammatory responses.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
Get a quote
Go top
